Press "Enter" to skip to content

Patent delisted for Helsinn Hlthcare drug ALOXI

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Helsinn Hlthcare drug ALOXI

Annual Drug Patent Expirations for ALOXI
Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from three suppliers. There are thirteen patents protecting this drug.

Drug patent litigation for ALOXI.

The generic ingredient in ALOXI is palonosetron hydrochloride. Three suppliers are listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Patent delisted for Helsinn Hlthcare drug ALOXI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions